Waystar Holding (WAY) Amends Credit Facilities

Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced an amendment to its first lien credit agreement (the "amended credit agreement") with its lenders. The amendment reprices Waystar's term loan and increases its revolving credit facility.

Under the amended agreement, the term loan will now carry a reduced interest rate of adjusted SOFR +2.25%, down from the previous interest rate of adjusted SOFR +2.75%. In addition, Waystar will increase its revolving credit facility borrowing capacity to $400 million, up from $342.5 million, and lower the interest rate to adjusted SOFR +1.75%, compared to the previous interest rate of adjusted SOFR +2.25%. These changes are expected to reduce borrowing costs and generate interest expense savings for the company.

The amendments follow Waystar's successful initial public offering on June 7, 2024, with net proceeds used to reduce debt, as well as an earlier loan repricing on June 27, 2024.

Additional details about the amended credit agreement are available in Waystar's Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 30, 2024. The filing is available on the investor relations page of Waystar's website at investors.waystar.com.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Sigma Lithium resumes full operations after signing TAC agreement